| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.9M | -42.5% |
| Cost of Revenue | $999K | -76.1% |
| Gross Profit | $2.9M | +11.0% |
| R&D Expense | $21.0M | -8.6% |
| SG&A Expense | $16.2M | +13.1% |
| Operating Income | -$40.1M | +6.1% |
| Pre-tax Income | -$37.6M | +1.4% |
| Income Tax | $57K | +102.1% |
| Net Income | -$37.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.9M | -80.3% |
| Short-term Investments | $26.8M | -38.6% |
| Accounts Receivable | $133K | -56.4% |
| Inventory | $1.1M | -35.6% |
| Current Assets | $32.3M | -48.0% |
| Total Assets | $64.0M | -32.9% |
| Current Liabilities | $7.3M | +27.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.2M | -32.0% |
| Capital Expenditures | $748K | -45.2% |
| Investing Cash Flow | $17.1M | +10.9% |
| Financing Cash Flow | $104K | +107.6% |
| Free Cash Flow | -$29.9M | -27.5% |
| -6.5% |
| EPS (Basic) | -$1.24 | -3.3% |
| EPS (Diluted) | -$1.24 | -3.3% |
| Total Liabilities |
| $9.7M |
| +4.1% |
| Stockholders' Equity | $54.3M | -36.9% |